To truly capture the potential of transformative innovations, many of which will take years to pay off, biopharma leaders need to trade their default “present-forward” mindset for one that is “future-back.”
Precision medicine necessitates precision research, which necessitates getting highly specific biospecimens to researchers on demand, in alignment with their demand. Researchers shouldn’t have to adjust their research to whatever specimens are available; supply needs to fit the research.
Organizational culture is very hard to define, and even harder to get right. Many leaders believe that culture is, above all else, the most important factor in driving innovation and organizational performance.